Project Details
| Short title | DT-7012-CLI-001 |
|---|---|
| Status | Active |
| Effective start/end date | 30/06/25 → 21/03/27 |
CTU: A Phase 1/2, multicentre, open-label clinical trial of DT-7012 as monotherapy and in combination with an immune checkpoint inhibitor in participants with selected advanced solid tumours
- Parsonson, Andrew (Primary Chief Investigator)
- Martin, Lewis (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
- Lawrie, Angus (Clinical Trial Unit Staff)
Project: Research